Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123122375 | 12312237 | 5 | F | 20160420 | 20160823 | 20160428 | 20160826 | EXP | CA-ROCHE-1748645 | ROCHE | 66.84 | YR | M | Y | 0.00000 | 20160826 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123122375 | 12312237 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0066B,S0001E,S0068D | 103976 | 375 | MG | SOLUTION FOR INJECTION | QOW | |||||
| 123122375 | 12312237 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0066B,S0001E,S0068D | 103976 | SOLUTION FOR INJECTION | ||||||||
| 123122375 | 12312237 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0066B,S0001E,S0068D | 103976 | SOLUTION FOR INJECTION | ||||||||
| 123122375 | 12312237 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0066B,S0001E,S0068D | 103976 | SOLUTION FOR INJECTION | ||||||||
| 123122375 | 12312237 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0066B,S0001E,S0068D | 103976 | SOLUTION FOR INJECTION | ||||||||
| 123122375 | 12312237 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0066B,S0001E,S0068D | 103976 | SOLUTION FOR INJECTION | ||||||||
| 123122375 | 12312237 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | S0066B,S0001E,S0068D | 103976 | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123122375 | 12312237 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123122375 | 12312237 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123122375 | 12312237 | Blood pressure increased | |
| 123122375 | 12312237 | Cough | |
| 123122375 | 12312237 | Dyspnoea | |
| 123122375 | 12312237 | Emotional distress | |
| 123122375 | 12312237 | Lower respiratory tract infection | |
| 123122375 | 12312237 | Oxygen saturation decreased | |
| 123122375 | 12312237 | Respiratory tract congestion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123122375 | 12312237 | 1 | 20160406 | 0 | ||
| 123122375 | 12312237 | 2 | 20160420 | 0 | ||
| 123122375 | 12312237 | 3 | 20160504 | 0 | ||
| 123122375 | 12312237 | 4 | 20160517 | 0 | ||
| 123122375 | 12312237 | 5 | 20160530 | 0 | ||
| 123122375 | 12312237 | 6 | 20160613 | 0 | ||
| 123122375 | 12312237 | 7 | 20160802 | 0 |